Scientists at San Antonio's Texas Biomedical Research Institute are studying the effectiveness of promising experimental cancer chemotherapy drugs ...
News
- SA researchers exploring use of re-purposed cancer drugs to combat deadly TB
- Assembly Biosciences (Call) (ASMB) Valuation Declined While Longwood Capital Partners ...
Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 70.43% since June 22, 2017 and is uptrending. It has outperformed by 57.86% the S&P500.
- Texas Biomed Slated for 10-Year Transformation as Challenges Loom
Texas Biomedical Research Institute in West San Antonio will retool over the next decade – doubling its faculty and redesigning its campus – to ...
- Repurposing promising cancer drugs may lead to a new approach to treating TB
A new study published by scientists at Texas Biomedical Research Institute in San Antonio pinpoints a mechanism in regulating cell death called ...
- 15-year-old graduates college with honors
On Monday, he graduated from the University of California Davis with a biomedical engineering degree while earning the highest honors, suma cum ...